Cambridge Cognition Holdings Plc (AIM:COG)

Market Cap	18.11M
Revenue (ttm)	13.08M
Net Income (ttm)	-1.32M
Shares Out	41.64M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	41,622
Average Volume	36,420
Open	46.00
Previous Close	45.50
Day's Range	43.00 - 46.00
52-Week Range	26.40 - 60.00
Beta	0.83
RSI	47.80
Earnings Date	May 2, 2025

About AIM:COG

Cambridge Cognition Holdings Plc, a neuroscience technology company, develops and markets near-patient cognitive testing techniques in the United States, United Kingdom, the European Union, and internationally. The company offers CANTAB digital cognitive assessment platform for drug development by enabling pharmaceutical companies to take new therapeutics from preclinical consultancy to pivotal studies and approval. It also offers eCOA, a data management tool for clinical scales which supports questionnaires and issue resolutions; and provides ...

• Industry: Medical - Healthcare Information Services
• Sector: Healthcare
• Founded: 2012
• Employees: 119
• Stock Exchange: London Stock Exchange AIM
• Ticker Symbol: COG

Financial Performance

In 2023, AIM:COG's revenue was 13.52 million, an increase of 7.15% compared to the previous year's 12.61 million. Losses were -3.51 million, 757.7% more than in 2022.